
Human Amyloid-beta precursor protein 172-186, DAEFRHDSGYEVHHQ
Description
About Human Amyloid-beta precursor protein 172-186, DAEFRHDSGYEVHHQ
The Human Amyloid beta (A4) protein HLA class I histocompatibility antigen, alpha chain F Peptide (IEDB: 99134) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Amyloid beta (A4) protein Peptide, H-DAEFRHDSGYEVHHQ-OH (Uniprot: P05067 aa: 172-186) from JPT is produced under strict quality control and quality management.
Human Amyloid-beta precursor protein 172-186, DAEFRHDSGYEVHHQ - Specifications
- Peptide sequence: H-DAEFRHDSGYEVHHQ-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Alzheimer's disease
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Amyloid-beta precursor protein 172-186, DAEFRHDSGYEVHHQ
References:
Read References with JPT’s Antigen Peptides
Human Amyloid-beta precursor protein 172-186, DAEFRHDSGYEVHHQ has been described in:
Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response., J Neurol Sci, 2008 (PMID: 18571202)
Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide., J Immunol, 2005 (PMID: 15661919)
Documentation
Documentation for Human Amyloid-beta precursor protein 172-186, DAEFRHDSGYEVHHQ
Properties
Properties of Human Amyloid-beta precursor protein 172-186, DAEFRHDSGYEVHHQ
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Alzheimer's disease |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Amyloid beta (A4) protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Amyloid-beta precursor protein 172-186, DAEFRHDSGYEVHHQ
Information | Values |
---|---|
Sequence: | H-DAEFRHDSGYEVHHQ-OH |
Specifications: | 15mer peptide as TFA salt |